MOLLER-SAN PEDRO CLAUS JUAN (Chief Executive Officer) purchased 3.7% of their position (31.25K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market purchase worth $500.0K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 9/25/2018ACC: 0001104659-18-058453
DirectorOfficer· Chief Executive Officer
Since Sep 2018
+31.25K
Net shares
Net buyer
$500.0K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
31.25K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+15.63K
Price / share
$16.00
Trade value
$250K
% of position
1.8%
9/25/2018
857.30K→872.93K
Common Stock
Indirect
Shares
+15.63K
Price / share
$16.00
Trade value
$250K
% of position
1.8%
9/25/2018
857.30K→872.93K
Total
Net shares
+31.25K
Net value
$500K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/25/2018 | P · Purchase | +15.63K | $16.00 | $250K | 1.8% | 857.30K | 872.93K |
| Common Stock Indirect | 9/25/2018 | P · Purchase | +15.63K | $16.00 | $250K | 1.8% | 857.30K | 872.93K |
| Total | +31.25K | $500K | ||||||
Derivative Transactions0
No derivative transactions reported